LUNG FIBROSIS

Clinical trials for LUNG FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new LUNG FIBROSIS trials appear

Sign up with your email to follow new studies for LUNG FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1

Could a chemo combo save lungs in scleroderma patients?

Disease control Completed

This study tested whether a combination of the chemotherapy drug cyclophosphamide and the steroid prednisone could help people with scleroderma-related lung disease. Forty adults whose lung function had worsened in the past year received either the drug combo or a placebo plus pr…

Matched conditions: LUNG FIBROSIS

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 26, 2026 16:08 UTC

LUNG FIBROSIS

Get alerted when new LUNG FIBROSIS trials appear

Could a chemo combo save lungs in scleroderma patients?